NSC-15041 |
DALFAMPRIDINE |
AMPYRA EXTENDED RELEASE |
AMPYRA |
EL-970 |
NEURELAN |
FAMPRIDINE |
FAMPYRA |
FAMPRIDINA |
4-PYRIDYLAMINE |
FAMPRIDINUM |
GAMMA-AMINOPYRIDINE |
FAMPRIDINE-SR |
N07XX07 |
4-AMINOPYRIDINE |
P-AMINOPYRIDINE |
AMPYRA® |
AVITROL |
4-PYRIDINAMINE |
4-AP |
chemidplus:504-24-5 |
chembl:CHEMBL284348 |
rxcui:897018 |
drugbank:06637 |
pubchem.compound:1727 |
Drug Class | ms-treatment |
Year of Approval | 2010 |
FDA Approval | 2010 |
Drug Class | small molecule |
Drug Indications | MS-treatment |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
antagonist (inhibitory) |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
antagonist (inhibitory) |
blocker (inhibitory) |
Novel drug target | Established target |
Trial Name | - |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
antagonist (inhibitory) |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
DALFAMPRIDINE | Primary Drug Name |
Year of Approval | 2010 |
Drug Class | ms-treatment |
Drug Indications | MS-treatment |
Drug Class | small molecule |
FDA Approval | 2010 |
D08YIN | TTD Drug ID |
CHEMBL284348 | ChEMBL Drug ID |